Day: December 29, 2022

Delta Drone SA confirms partial sale of DLT Shares

Written by Customer Service on December 29, 2022. Posted in Mergers And Acquisitions.

Delta Drone SA confirms partial sale of DLT Shares Dardilly, 29 December 2022 – 6.30 pm Delta Drone International Limited (“Company” or “DLT”) (ASX: DLT), a Global drones-as-a-service provider, has confirmed that its major shareholder Delta Drone Société Anonyme (Delta Drone SA), has disposed of part of its shareholding in DLT. Delta Drone SA engaged the services of Baker Young Advisory to sell 85,812,067 fully paid ordinary shares it held in DLT, which was executed as a special crossing/block trade, equating to 16.77% of ordinary issued shares in DLT. Baker Young Advisory has confirmed that the trade was placed with several independent institutional and professional investors at a price of $0.005 per share. About Delta Drone: Delta Drone Group is a recognized international player in the field of civilian drones for professional use....

Ilkka Oyj – Acquisition of own shares on 29 December 2022

Written by Customer Service on December 29, 2022. Posted in Public Companies.

ILKKA OYJ, STOCK EXCHANGE RELEASE, 29 December 2022 at 19:00 EET Ilkka Oyj – Acquisition of own shares on 29 December 2022 At Nasdaq Helsinki Ltd:Date 29 December 2022Exchange transaction BuyShare trading code ILKKA2Amount, shares 1,400Average price/share, EUR 3.6089Total cost, EUR 5,052.46The company holds a total of 21,635 of its own shares (ILKKA2) including the shares acquired on 29 December 2022. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Ilkka Oyj DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg Antti Väliaho Additional information Olli Pirhonen, CEO, Ilkka Oyj, tel. +358 40 766 5418 www.ilkka.comAttachmentIlkka buyback 29.12.2022

The 30-Year Fixed-Rate Moves Higher

Written by Customer Service on December 29, 2022. Posted in Public Companies.

Primary Mortgage Market Survey® U.S. weekly average mortgage rates as of 12 29 2022MCLEAN, Va., Dec. 29, 2022 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.42 percent. “The housing market remains in the doldrums with declining sales, inventory and prices,” said Sam Khater, Freddie Mac’s Chief Economist. “The declines in sales and deceleration in home prices began swiftly earlier in 2022 but have moderated more recently. While the intensity of weakness is moderating, the market continues to decline and forward leading indicators suggest housing will remain weak throughout the winter.” News Facts30-year fixed-rate mortgage averaged 6.42 percent as of December 29, 2022, up from last week when it averaged...

AB Science has received approval from the U.S. Food and Drug Administration (FDA) to initiate the confirmatory Phase 3 study with masitinib in the treatment of progressive multiple sclerosis

Written by Customer Service on December 29, 2022. Posted in Public Companies.

PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) TO INITIATE THE CONFIRMATORY PHASE 3 STUDY WITH MASITINIB IN THE TREATMENT OF PROGRESSIVE MULTIPLE SCLEROSIS Paris, December 29 2022, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) announced today that its Phase III clinical trial (AB20009) in progressive forms of multiple sclerosis has been approved by the US Food and Drug Administration (FDA). This decision follows authorizations received from several European countries, including the French Agency (ANSM). This approval to initiate a confirmatory study in neurology is the third obtained from the FDA after studies in Amyotrophic Lateral Sclerosis (AB19001) and Alzheimer’s disease (AB21004). Study AB20009 is actively recruiting patients. This is a randomized, double-blind,...

Nextensa sells the Titanium site in the Grand Duchy of Luxembourg to Codic, for 110 million euros

Written by Customer Service on December 29, 2022. Posted in Mergers And Acquisitions.

PRESS RELEASE Brussels, 29 December 2022, 5.40 PMNextensa sells the Titanium site in the Grand Duchy of Luxembourg to Codic, for 110 million eurosCodic is a Belgian real estate player operating in Belgium, Luxembourg, France, Spain and Hungary. In November 2021, Nextensa signed an agreement with Codic to sell 100% of the shares of the Luxembourg company GK5 Sàrl, owner of the Titanium site in the Cloche d’Or district, under conditions precedent. The effective transfer of the shares took place today. The total investment reaches 110 million euros. With this sale, the real estate investor and developer Nextensa realises a significant capital gain in the last quarter of 2022. Furthermore, the rental income from the Titanium building on the site – representing approximately 2.6 million euros in 2022 – is still contributing...

Innofactor Plc: Share Repurchase 29.12.2022

Written by Customer Service on December 29, 2022. Posted in Public Companies.

Innofactor Plc Announcement 29.12.2022 Innofactor Plc: Share Repurchase 29.12.2022 In the Helsinki Stock Exchange Trade date 29.12.2022 Bourse trade Buy Share IFA1V Amount 9,000 SharesAverage price/ share 1.0798 EURTotal cost 9,718.20 EUR Innofactor Plc now holds a total of 1 171 121 sharesincluding the shares repurchased on 29.12.2022 On behalf of Innofactor Plc Nordea Bank Oyj Janne Sarvikivi Sami Huttunen Additional information: Sami Ensio, CEO Innofactor Plc Tel. +358 50 584 2029 sami.ensio@innofactor.com www.innofactor.com AttachmentInnofactor_29.12_trades

BitFrontier Capital Holdings, Inc. Announces Year End Shareholder Letter

Written by Customer Service on December 29, 2022. Posted in Public Companies.

CRESTVIEW, FL, Dec. 29, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BitFrontier Capital Holdings, Inc. (OTC: BFCH) is providing this year end summary showing their accomplishments, ongoing actions, and outstanding issues and progress made in major projects. BFCH current and future shareholders, After acquiring the company via court appointed custodian back in August, we’ve been quite successful in the turnaround efforts thus far. Over the last few months we’ve added well qualified personnel to the board, paid off all existing bills from prior management, regained current status, relaunched mining efforts, formed Liquid Immersion Worldwide, and signed a LOI with one of the largest Asic Miner resellers in the United States. I would like to touch lightly on many things before we head into the new year in hopes that all questions...

Clearday’s Companion Robotics Solution Mitra Selected for Pennsylvania Pilot Program

Written by Customer Service on December 29, 2022. Posted in Public Companies.

San Antonio, Texas, Dec. 29, 2022 (GLOBE NEWSWIRE) — Clearday, Inc. (OTCQX: CLRD) (“Clearday” or the “Company”) is pleased to announce that TRECS Institute has applied for a grant from the Pennsylvania State Civil Penalty Fund to access funds for skilled nursing facilities to purchase Mitra robots from Clearday that will have Clearday’s full suite of robotic services including its proprietary digital programming, “Clearday at Home”. The Mitra robot is expected to elevate the care options for skilled nursing communities across the country. This application by TRECS is the pilot program for the TRECS and Clearday strategy to access similar funds to greatly enhance Clearday’s ability to sell or rent, as a service, its Mitra robots to skilled nursing facilities nationwide. The Company recently received a provisional order from their...

DIVIDEND ANNOUNCEMENT: ZEGA Buy and Hedge ETF (NYSE: ZHDG) on 12/22/2022 declared a dividend of $0.5667 per share

Written by Customer Service on December 29, 2022. Posted in Dividend Reports And Estimates.

WEST PALM BEACH, Fla., Dec. 29, 2022 (GLOBE NEWSWIRE) — ZEGA Buy and Hedge ETF/Tidal ETF Trust (NYSE: ZHDG) on December 22, 2022 declared a dividend of $0.5667 per share payable on December 28, 2022 to shareholders of record as of December 27, 2022. Dividend amount recorded is an increase of $0.2867 from last dividend paid. The ZEGA Buy and Hedge ETF (NYSE: ZHDG), has a current dividend yield of 3.46%. The 30-day SEC yield is 3.12%. The stock price closed December 22, 2022 at $16.37 and has a 52-week high/low of $21.20 and $16.20. For more information and to view standardized returns for ZEGA Buy and Hedge ETF click here. ZEGA Buy and Hedge ETF current dividend information as per the date of this press release is: Dividend Declaration Date: December 22, 2022Dividend Ex Date: December 23, 2022Dividend Record Date: December 27, 2022Dividend...

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2022 and Provides Corporate Update

Written by Customer Service on December 29, 2022. Posted in Earnings Releases And Operating Results.

Attained U.S. Food and Drug Administration (FDA) Prescription Drug User Fee Act (PDUFA) goal date of August 29, 2023 for ONS-5010 / LYTENAVA™ (bevacizumab-vikg), an investigational ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD)Secured approximately $55 million gross proceeds from recent financings, expected to provide funding through the anticipated FDA approval of ONS-5010 in the third calendar quarter of 2023ISELIN, N.J., Dec. 29, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced its financial results for its fiscal year ended September 30, 2022, and provided recent corporate...

Day: December 29, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals